BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16949483)

  • 1. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
    Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
    J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
    James SK; Lindbäck J; Tilly J; Siegbahn A; Venge P; Armstrong P; Califf R; Simoons ML; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2006 Sep; 48(6):1146-54. PubMed ID: 16978997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
    James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
    Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
    Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett DH; Georgescu AA; Hassan Q; Luchansky J; Langer A; Goodman SG;
    Am Heart J; 2006 Aug; 152(2):270-6. PubMed ID: 16875907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.
    Bazzino O; Fuselli JJ; Botto F; Perez De Arenaza D; Bahit C; Dadone J;
    Eur Heart J; 2004 May; 25(10):859-66. PubMed ID: 15140534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
    Lim KD; Yan AT; Casanova A; Yan RT; Mendelsohn A; Jolly S; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2008 Apr; 155(4):718-24. PubMed ID: 18371482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined prognostic utility of ST segment in lead aVR and troponin T on admission in non-ST-segment elevation acute coronary syndromes.
    Kosuge M; Kimura K; Ishikawa T; Ebina T; Hibi K; Tsukahara K; Kanna M; Iwahashi N; Okuda J; Nozawa N; Ozaki H; Yano H; Kusama I; Umemura S
    Am J Cardiol; 2006 Feb; 97(3):334-9. PubMed ID: 16442391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes.
    Galvani M; Ottani F; Oltrona L; Ardissino D; Gensini GF; Maggioni AP; Mannucci PM; Mininni N; Prando MD; Tubaro M; Vernocchi A; Vecchio C;
    Circulation; 2004 Jul; 110(2):128-34. PubMed ID: 15197143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
    Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.
    Savonitto S; Cohen MG; Politi A; Hudson MP; Kong DF; Huang Y; Pieper KS; Mauri F; Wagner GS; Califf RM; Topol EJ; Granger CB
    Eur Heart J; 2005 Oct; 26(20):2106-13. PubMed ID: 15987706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.